Clinical evaluation of indoramin as the sole agent for the treatment of hypertension.
D000959:Antihypertensive Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001549:Benzamides / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D007211:Indoles / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010880:Piperidines / Q000627:therapeutic use; D011507:Proteinuria / Q000139:chemically induced
D000959:Antihypertensive Agents; D001549:Benzamides; D007211:Indoles; D010880:Piperidines